Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells.

Shigella dysenteriae and Shiga-toxin-producing Escherichia coli (STEC) elaborate the AB holotoxins, Shiga or Shiga-like toxins (Stx). Stx play a major role in the pathogenesis of haemorrhagic colitis and haemolytic uremic syndrome. This review provides an overview of the mechanisms of action of Stx and a model of the pathogenesis of Stx-induced disease.

[1]  C. Lingwood,et al.  Verotoxin receptor glycolipid in human renal tissue. , 1989, Nephron.

[2]  B. Caillou,et al.  Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen. , 1993, Cancer research.

[3]  W. Rand,et al.  Central nervous system manifestations of childhood shigellosis: prevalence, risk factors, and outcome. , 1999, Pediatrics.

[4]  L. M. Sung,et al.  Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II , 1990, Infection and immunity.

[5]  J. Samuel,et al.  Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents. , 1999, The Journal of infectious diseases.

[6]  G. Tyrrell,et al.  Alteration of the carbohydrate binding specificity of verotoxins from Gal alpha 1-4Gal to GalNAc beta 1-3Gal alpha 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Brown,et al.  Direct cytotoxic action of Shiga toxin on human vascular endothelial cells , 1988, Infection and immunity.

[8]  C. Lingwood,et al.  Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. , 1987, The Journal of biological chemistry.

[9]  J. Samuel,et al.  Evidence that proteolytic separation of Shiga-like toxin type IIv A subunit into A1 and A2 subunits is not required for toxin activity. , 1994, The Journal of biological chemistry.

[10]  R J Read,et al.  Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3. , 1998, Biochemistry.

[11]  M. Breimer,et al.  Glycosphingolipids of human large intestine: detailed structural characterization with special reference to blood group compounds and bacterial receptor structures. , 1991, Journal of biochemistry.

[12]  A. Dunker,et al.  Evidence that the A2 fragment of Shiga-like toxin type I is required for holotoxin integrity , 1994, Infection and immunity.

[13]  M. Thompson,et al.  Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli. , 1982, The Journal of infectious diseases.

[14]  A. Macpherson,et al.  Intestinal permeability: an overview. , 1995, Gastroenterology.

[15]  J Konowalchuk,et al.  Vero response to a cytotoxin of Escherichia coli , 1977, Infection and immunity.

[16]  M. Levine,et al.  Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery. , 1973, The Journal of infectious diseases.

[17]  G. Fernández,et al.  Pretreatment of mice with lipopolysaccharide (LPS) or IL‐1β exerts dose‐dependent opposite effects on Shiga toxin‐2 lethality , 2000, Clinical and experimental immunology.

[18]  G. Keusch,et al.  Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin. , 1994, The Journal of infectious diseases.

[19]  S. Olsnes,et al.  The cytotoxic activity of Shigella toxin. Evidence for catalytic inactivation of the 60 S ribosomal subunit. , 1981, The Journal of biological chemistry.

[20]  L. Wieler,et al.  Shiga Toxin 1 from Escherichia coliBlocks Activation and Proliferation of Bovine Lymphocyte Subpopulations In Vitro , 1999, Infection and Immunity.

[21]  L. Johannes,et al.  Surfing on a retrograde wave: how does Shiga toxin reach the endoplasmic reticulum? , 1998, Trends in cell biology.

[22]  G. van Meer,et al.  Importance of glycolipid synthesis for butyric acid-induced sensitization to shiga toxin and intracellular sorting of toxin in A431 cells. , 1996, Molecular biology of the cell.

[23]  S. Gorbach,et al.  PURIFICATION OF SHIGELLA DYSENTERIAE 1 (SHIGA)-LIKE TOXIN FROM ESCHERICHIA COLI 0157:H7 STRAIN ASSOCIATED WITH HAEMORRHAGIC COLITIS , 1983, The Lancet.

[24]  V. V. van Hinsbergh,et al.  Plasma cytokine levels in hemolytic uremic syndrome. , 1995, Nephron.

[25]  G. Keusch,et al.  The pathogenesis of Shigella diarrhea. V. Relationship of shiga enterotoxin, neurotoxin, and cytotoxin. , 1975, The Journal of infectious diseases.

[26]  K. Sandvig,et al.  Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin. , 1996, Physiological reviews.

[27]  C. Lingwood,et al.  Interaction of verotoxin 2e with pig intestine , 1996, Infection and immunity.

[28]  C. Ackerley,et al.  Translocation of verotoxin-1 across T84 monolayers: mechanism of bacterial toxin penetration of epithelium. , 1997, American journal of physiology. Gastrointestinal and liver physiology.

[29]  M. Isturiz,et al.  Depletion of liver and splenic macrophages reduces the lethality of Shiga toxin‐2 in a mouse model , 1999, Clinical and experimental immunology.

[30]  H. Kondo,et al.  Inhibition of Neutrophil Apoptosis by Verotoxin 2 Derived from Escherichia coli O157:H7 , 1999, Infection and Immunity.

[31]  C. Lingwood,et al.  Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function. , 1991, The Journal of biological chemistry.

[32]  V. L. Tesh,et al.  Shiga Toxin Type 1 Activates Tumor Necrosis Factor-α Gene Transcription and Nuclear Translocation of the Transcriptional Activators Nuclear Factor-κB and Activator Protein-1 , 1998 .

[33]  M. P. Jackson,et al.  Roles of a ribosome-binding site and mRNA secondary structure in differential expression of Shiga toxin genes , 1993, Journal of bacteriology.

[34]  Randy J. Read,et al.  Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli , 1992, Nature.

[35]  D. Adu,et al.  Cytokines in haemolytic uraemic syndrome associated with verocytotoxin-producing Escherichia coli infection , 1997, Archives of disease in childhood.

[36]  J. Mekalanos,et al.  Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus , 1987, Journal of bacteriology.

[37]  R. Holmes,et al.  Cloning of Shiga-like toxin structural genes from a toxin converting phage of Escherichia coli. , 1985, Science.

[38]  H. Uchida,et al.  The Detection of Shiga Toxins in the Kidney of a Patient with Hemolytic Uremic Syndrome , 1999, Pediatric Research.

[39]  C. Lingwood,et al.  Endothelial heterogeneity in Shiga toxin receptors and responses. , 1993, The Journal of biological chemistry.

[40]  G. Keusch,et al.  Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin- binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide , 1986, The Journal of experimental medicine.

[41]  J. Brown,et al.  The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis. , 1987, The Biochemical journal.

[42]  S. Yoshida,et al.  Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2 , 1996, Infection and immunity.

[43]  G. Remuzzi,et al.  Verotoxin-1 promotes leukocyte adhesion to cultured endothelial cells under physiologic flow conditions. , 1995, Blood.

[44]  A. Melton-Celsa.  Structure, biology, and relative toxicity of Shiga toxin family members for cells and animals , 1998 .

[45]  D. Acheson,et al.  Translocation of Shiga toxin across polarized intestinal cells in tissue culture , 1996, Infection and immunity.

[46]  C. Lingwood,et al.  Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[47]  T. Yutsudo,et al.  Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. , 1988, European journal of biochemistry.

[48]  S. Homans,et al.  Solution structure of the carbohydrate-binding B-subunit homopentamer of verotoxin VT-1 from E. coli , 1997, Nature Structural Biology.

[49]  E. Avner,et al.  Escherichia coli O 157:H7-associated hemolytic-uremic syndrome after ingestion of contaminated hamburgers. , 1994, The Journal of pediatrics.

[50]  R. Holmes,et al.  Shiga and Shiga-like toxins. , 1987, Microbiological reviews.

[51]  J. LaMarre,et al.  Binding of Escherichia coli verotoxins to cell surface protein on wild-type and globotriaosylceramide-deficient Vero cells. , 1998, Canadian journal of microbiology.

[52]  J. Samuel,et al.  Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice , 1993, Infection and immunity.

[53]  L. Pickering,et al.  The association of Shiga toxin and other cytotoxins with the neurologic manifestations of shigellosis. , 1990, The Journal of infectious diseases.

[54]  G. Tyrrell,et al.  Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs , 1993, The Journal of experimental medicine.

[55]  S. Palchaudhuri,et al.  Regulation of the SLT-1A toxin operon by a ferric uptake regulatory protein in toxinogenic strains of Shigella dysenteriae type 1. , 1992, Journal of diarrhoeal diseases research.

[56]  S. Grinstein,et al.  pH-independent retrograde targeting of glycolipids to the Golgi complex. , 1998, American journal of physiology. Cell physiology.

[57]  B. Bell,et al.  Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. , 1997, Pediatrics.

[58]  K. Sandvig,et al.  Furin-induced Cleavage and Activation of Shiga Toxin (*) , 1995, The Journal of Biological Chemistry.

[59]  V. V. van Hinsbergh,et al.  Effects of TNFα on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells , 1997 .

[60]  V. L. Tesh,et al.  Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines , 1996, Infection and immunity.

[61]  R. Dubos,et al.  PREPARATION AND PROPERTIES OF SHIGA TOXIN AND TOXOID , 1946, The Journal of experimental medicine.

[62]  S. Adler,et al.  Glomerular Endothelial Cell Injury Mediated by Shiga-Like Toxin-1 , 1998, Kidney and Blood Pressure Research.

[63]  P. Sansonetti,et al.  Molecular and cellular biology of Shigella flexneri invasiveness: from cell assay systems to shigellosis. , 1992, Current topics in microbiology and immunology.

[64]  A. O’Brien,et al.  Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice , 1996, Infection and immunity.

[65]  M. Ogata,et al.  Hepatic and muscle injuries in mice treated with heptachlor. , 1990, Toxicology letters.

[66]  R. Holmes,et al.  Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities , 1986, Infection and immunity.

[67]  R. Holmes,et al.  Effects of iron and temperature on Shiga-like toxin I production by Escherichia coli , 1988, Infection and immunity.

[68]  James C. Paton,et al.  Pathogenesis and Diagnosis of Shiga Toxin-Producing Escherichia coli Infections , 1998, Clinical Microbiology Reviews.

[69]  A. Akatsuka,et al.  Induction of glomerular lesions in the kidneys of mice infected with vero toxin-producing Escherichia coli by lipopolysaccharide injection. , 1999, The Journal of infectious diseases.

[70]  D. Acheson,et al.  Regulation of the Shiga-like toxin II operon in Escherichia coli , 1996, Infection and immunity.

[71]  Y. Ihara,et al.  Localization of verotoxin receptors in nervous system , 1999, Brain Research.

[72]  Nobuhiro Fujii,et al.  Role of Tumor Necrosis Factor Alpha in Gnotobiotic Mice Infected with an Escherichia coli O157:H7 Strain , 1998, Infection and Immunity.

[73]  H R Smith,et al.  Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects. , 1990, Archives of disease in childhood.

[74]  T. L. Hale,et al.  Genetic basis of virulence in Shigella species. , 1991, Microbiological reviews.

[75]  C. Lingwood,et al.  cells to Shiga toxin . sensitivity of human umbilical vein endothelial syndrome : effect of sodium butyrate on Shiga toxin-associated hemolytic uremic , 1991 .

[76]  C. Lingwood.  Verotoxin-binding in human renal sections. , 1994, Nephron.

[77]  F. Scheutz,et al.  The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection. , 1997, The Journal of infectious diseases.

[78]  W. R. Rout,et al.  Pathophysiology of Shigella diarrhea in the rhesus monkey: intestinal transport, morphological, and bacteriological studies. , 1974, Gastroenterology.

[79]  A. Caprioli,et al.  Apoptosis of Renal Cortical Cells in the Hemolytic-Uremic Syndrome: In Vivo and In Vitro Studies , 1998, Infection and Immunity.

[80]  H. Lior,et al.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. , 1985, The Journal of infectious diseases.

[81]  R. Siegler.  Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome. , 1994, The Journal of pediatrics.

[82]  T. Obrig,et al.  Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells. , 1995, The Journal of infectious diseases.

[83]  G. Keusch,et al.  Pathogenesis of Shigella diarrhea: rabbit intestinal cell microvillus membrane binding site for Shigella toxin , 1986, Infection and immunity.

[84]  J. Samuel,et al.  Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages , 1994, Infection and immunity.

[85]  A. O’Brien,et al.  Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli , 1983, Infection and immunity.

[86]  L. Becker,et al.  The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. , 1988, Human pathology.

[87]  J. Wells,et al.  Production of Shiga-like toxin by Escherichia coli. , 1986, The Journal of infectious diseases.

[88]  C. Young,et al.  Murine neurovirulence studies with a chimeric poliovirus: in vivo generation of a mutant base-paired stable attenuated poliovirus. , 1998, Microbial pathogenesis.

[89]  V. Jay,et al.  Experimental verocytotoxemia in rabbits , 1992, Infection and immunity.

[90]  J. Wallace,et al.  Do eicosanoids cause colonic dysfunction in experimentalE coli 0157:H7 (EHEC) infection? , 2000, Gut.

[91]  S. Formal,et al.  ESCHERICHIA COLI 0157:H7 STRAINS ASSOCIATED WITH HAEMORRHAGIC COLITIS IN THE UNITED STATES PRODUCE A SHIGELLA DYSENTERIAE 1 (SHIGA) LIKE CYTOTOXIN , 1983, The Lancet.

[92]  D. Thorley-Lawson,et al.  Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies , 1984, The Journal of experimental medicine.

[93]  H. Uchida,et al.  Induction of apoptosis in normal human renal tubular epithelial cells by Escherichia coli Shiga toxins 1 and 2. , 1998, The Journal of infectious diseases.

[94]  M. James,et al.  Crystal structure of the holotoxino from Shigella dysenteriae at 2.5 Å resolution , 1994, Nature Structural Biology.

[95]  Ludger Johannes,et al.  Rab6 Coordinates a Novel Golgi to ER Retrograde Transport Pathway in Live Cells , 1999, The Journal of cell biology.

[96]  R. Read,et al.  The identification of three biologically relevant globotriaosyl ceramide receptor binding sites on the Verotoxin 1 B subunit , 1999, Molecular microbiology.

[97]  G. Keusch,et al.  Quantitation of the rabbit intestinal glycolipid receptor for Shiga toxin. Further evidence for the developmental regulation of globotriaosylceramide in microvillus membranes. , 1989, Gastroenterology.

[98]  H. Karch,et al.  Purified verotoxins of Escherichia coli O157:H7 decrease prostacyclin synthesis by endothelial cells. , 1988, Microbial pathogenesis.

[99]  D. Acheson,et al.  Shiga Toxins Stimulate Secretion of Interleukin-8 from Intestinal Epithelial Cells , 1999, Infection and Immunity.

[100]  D. Acheson,et al.  Responses of Human Intestinal Microvascular Endothelial Cells to Shiga Toxins 1 and 2 and Pathogenesis of Hemorrhagic Colitis , 1999, Infection and Immunity.

[101]  J. Brown,et al.  Shiga toxin from Shigella dysenteriae 1 inhibits protein synthesis in reticulocyte lysates by inactivation of aminoacyl-tRNA binding. , 1986, Microbial pathogenesis.

[102]  James P. Nataro,et al.  Diarrheagenic Escherichia coli , 1998, Clinical Microbiology Reviews.

[103]  D. Acheson,et al.  Shiga toxin induces superoxide production in polymorphonuclear cells with subsequent impairment of phagocytosis and responsiveness to phorbol esters. , 1999, Journal of Infectious Diseases.

[104]  T. Takeda,et al.  Impairment by verotoxin of tubular function contributes to the renal damage seen in haemolytic uraemic syndrome. , 1993, The Journal of infection.

[105]  E. Boedeker,et al.  Role of Shiga-like toxin I in bacterial enteritis: comparison between isogenic Escherichia coli strains induced in rabbits. , 1994, Gastroenterology.

[106]  C. Lingwood,et al.  Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro , 1993, Infection and immunity.

[107]  K. Sandvig,et al.  Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP , 1994, The Journal of cell biology.

[108]  P. Stricklett,et al.  Shiga toxin-1 regulation of cytokine production by human proximal tubule cells. , 1998, Kidney international.

[109]  T. Obrig,et al.  Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro , 1992, Infection and immunity.

[110]  M. Bennish.  Potentially lethal complications of shigellosis. , 1991, Reviews of infectious diseases.

[111]  M. Petric,et al.  SPORADIC CASES OF HAEMOLYTIC-URAEMIC SYNDROME ASSOCIATED WITH FAECAL CYTOTOXIN AND CYTOTOXIN-PRODUCING ESCHERICHIA COLI IN STOOLS , 1983, The Lancet.

[112]  B. Beutler,et al.  A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome. , 1993, The Journal of clinical investigation.

[113]  M. P. Jackson,et al.  Identification of a B subunit gene promoter in the Shiga toxin operon of Shigella dysenteriae 1 , 1992, Journal of bacteriology.

[114]  R. Verwilghen,et al.  Chromosome analysis in two unusual malignant blood disorders presumably induced by benzene , 1979 .

[115]  P. Stricklett,et al.  Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells. , 1998, Kidney international.

[116]  M. Donowitz,et al.  Effect of Shigella enterotoxin on electrolyte transport in rabbit ileum. , 1975, Gastroenterology.

[117]  J. Belch,et al.  Disturbances of prostacyclin metabolism in children with hemolytic-uremic syndrome and in first degree relatives. , 1986, Clinical nephrology.

[118]  C. Lingwood,et al.  Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriaosyl ceramide fatty acid isoform traffic , 1998, Journal of cellular physiology.

[119]  J. Cavanagh,et al.  The neurotoxin of Shigella shigae; a comparative study of the effects produced in various laboratory animals. , 1956, British journal of experimental pathology.

[120]  H. Abboud,et al.  Shiga toxin 1 elicits diverse biologic responses in mesangial cells. , 1998, Kidney international.

[121]  J. Wallace,et al.  Modulation of host response to Escherichia coli o157:H7 infection by anti-CD18 antibody in rabbits. , 1994, Gastroenterology.

[122]  J. Samuel,et al.  Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants , 1990, Infection and immunity.

[123]  K. Sandvig,et al.  Role of processing and intracellular transport for optimal toxicity of Shiga toxin and toxin mutants. , 1995, Experimental cell research.

[124]  P. Sansonetti,et al.  Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied by using a Tox- mutant of Shigella dysenteriae 1 , 1988, Infection and immunity.

[125]  R. Pepperkok,et al.  The KDEL retrieval system is exploited by Pseudomonas exotoxin A, but not by Shiga-like toxin-1, during retrograde transport from the Golgi complex to the endoplasmic reticulum. , 1999, Journal of cell science.

[126]  D. Acheson,et al.  Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells. , 1995, The Journal of clinical investigation.

[127]  J. Robertus,et al.  Shiga toxin attacks bacterial ribosomes as effectively as eucaryotic ribosomes. , 1998, Biochemistry.

[128]  R. Holmes,et al.  Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. , 1984, Science.

[129]  M. P. Jackson,et al.  Identification of the Shiga toxin A-subunit residues required for holotoxin assembly , 1993, Journal of bacteriology.

[130]  G. Keusch,et al.  The pathogenesis of Shigella diarrhea. I. Enterotoxin production by Shigella dysenteriae I. , 1972, The Journal of clinical investigation.

[131]  M. Brezis,et al.  Shiga toxin induces medullary tubular injury in isolated perfused rat kidneys. , 1997, FEMS immunology and medical microbiology.

[132]  S. Yoshida,et al.  Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice , 1994, Infection and immunity.

[133]  Yang Wang,et al.  Verotoxin and ricin have novel effects on preproendothelin-1 expression but fail to modify nitric oxide synthase (ecNOS) expression and NO production in vascular endothelium. , 1998, The Journal of clinical investigation.

[134]  S. Tzipori,et al.  Cerebral infection with Escherichia coli O157:H7 in humans and gnotobiotic piglets. , 1988, Journal of clinical pathology.

[135]  D. Milford,et al.  A comparison of the effects of verocytotoxin-1 on primary human renal cell cultures. , 1999, Toxicology letters.

[136]  E. O'Loughlin,et al.  The effect of enterohemorrhagic Escherichia coli O157:H7 on intestinal structure and solute transport in rabbits. , 1993, Gastroenterology.

[137]  Kristian Prydz,et al.  Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum , 1992, Nature.

[138]  C. Lingwood,et al.  Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues. , 1994, The Journal of biological chemistry.

[139]  J. Brown,et al.  Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. , 1987, The Journal of biological chemistry.

[140]  T. Obrig,et al.  Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro. , 1994, Microvascular research.

[141]  R. Petras,et al.  Escherichia coli 0157:H7-associated colitis: A clinical and histological study of 11 cases , 1990 .

[142]  M. P. Jackson,et al.  Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. , 1992, Current topics in microbiology and immunology.